SINGAPORE (Oct 3): Ugur Sahin, CEO of BioNTech, sees a need for an updated Covid-19 vaccine by middle of next year as the virus further mutates.

BioNTech, together with Pfizer, developed what has been described as the first vaccine late last year.

“This year [a different vaccine] is completely unneeded. But by mid next year, it could be a different situation,” said Sahin in an interview with...(click on link for full story on theedgesingapore.com)